Status:
COMPLETED
Acute Kidney Injury Risk in COVID-19
Lead Sponsor:
Zagazig University
Collaborating Sponsors:
University of Ha'il , Saudi Arabia.
Conditions:
Sever Acute Respiratory Syndrome and Acute Kidney Injury
Acute Kidney Injury
Eligibility:
All Genders
18+ years
Brief Summary
Background. Within a year, COVID-19 has advanced from being an outbreak to a pandemic, spreading rapidly and globally with devastating impact. Currently, there is an ongoing debate among scientists ab...
Detailed Description
2.1. Study design and participants. Retrospective observational single-center study, including (83) laboratory-confirmed COVID-19 patients (age ≥ 18 years), hospitalized and isolated in the medical de...
Eligibility Criteria
Inclusion
- According to the WHO guidelines, a confirmed diagnosis of COVID-19 was defined as a positive result of a quantitative real-time reverse-transcriptase-polymerase chain reaction (RT-PCR) detection in a nasopharyngeal swab.
Exclusion
- patients younger than 18 years, patients diagnosed with chronic kidney disease before admission, patients on maintenance dialysis or awaiting renal transplantation and patients taking any nephrotoxic medications a week prior to admission
Key Trial Info
Start Date :
June 8 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2021
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT04874779
Start Date
June 8 2020
End Date
May 1 2021
Last Update
July 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine -Zagazig University
Zagazig, Egypt